DLL4 overexpression increases gastric cancer stem/progenitor cell self‐renewal ability and correlates with poor clinical outcome via Notch‐1 signaling pathway …

ZF Miao, H Xu, HM Xu, ZN Wang, TT Zhao… - Cancer …, 2017 - Wiley Online Library
Gastric cancer is one of the most common malignant diseases, and poses a serious threat to
the quality of human life. Gastric cancer stem/progenitor cells (GCSPCs) have critical effects …

[HTML][HTML] Clinical implications of DLL4 expression in gastric cancer

S Ishigami, T Arigami, Y Uenosono, H Okumura… - Journal of Experimental …, 2013 - Springer
Background Delta-like ligand 4 (DLL4)-Notch signaling plays a key role in tumor
neovascular development and angiogenesis during tumor growth. The clinical significance …

[HTML][HTML] Stable silencing of dll4 gene suppresses the growth and metastasis of esophagus cancer cells by attenuating Akt phosphorylation

X Guo, Y Duan, X Ye, L Hu, T Xu… - Oncology …, 2018 - spandidos-publications.com
Abstract δ‑Like ligand 4 (DLL4) has recently been reported to be involved in the process of
cancer angiogenesis and considered to play a vital role in vascular endothelial growth factor …

[HTML][HTML] Influence of up-regulation of Notch ligand DLL4 on biological behaviors of human gastric cancer cells

GG Li, L Li, C Li, LY Ye, XW Li, DR Liu… - World Journal of …, 2013 - ncbi.nlm.nih.gov
AIM: To investigate the potential roles of Delta-like ligand 4 (DLL4) on the biological
behavior of gastric cancer cells and its molecular mechanisms. METHODS: A recombinant …

[HTML][HTML] High delta-like ligand 4 expression correlates with a poor clinical outcome in gastric cancer

Y Kim, S Byeon, J Hur, K Lee, D Kim, JH Ahn… - Journal of …, 2019 - ncbi.nlm.nih.gov
Background: Emerging evidence suggests that delta-like ligand 4 (DLL4) and other
members of the Notch pathway may offer new targets for development of anti-angiogenesis …

[HTML][HTML] High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients

C Yuan, K Chang, C Xu, Q Li, Z Du - Translational Oncology, 2021 - Elsevier
Background Previous studies have shown the prognostic value of delta like canonical Notch
ligand 3 (DLL3) in patients with different types of tumors, but the role and predictive value of …

[HTML][HTML] Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer

G Piazzi, L Fini, M Selgrad, M Garcia, Y Daoud, T Wex… - Oncotarget, 2011 - ncbi.nlm.nih.gov
The Notch signaling pathway drives proliferation, differentiation, apoptosis, cell fate, and
maintenance of stem cells in several tissues. Aberrant activation of Notch signaling has …

DLL 3 regulates the migration and invasion of small cell lung cancer by modulating Snail

M Furuta, H Kikuchi, T Shoji, Y Takashima… - Cancer …, 2019 - Wiley Online Library
Delta‐like protein 3 (DLL 3) is a ligand of Notch signaling, which mediates cell‐fate
decisions and is tumor‐suppressive or oncogenic depending on the cellular context …

Delta like ligand 4 induces impaired chemo-drug delivery and enhanced chemoresistance in pancreatic cancer

M Kang, B Jiang, B Xu, W Lu, Q Guo, Q Xie, B Zhang… - Cancer letters, 2013 - Elsevier
The stubborn chemoresistance of pancreatic ductal adenocarcinoma (PDA) is
simultaneously influenced by tumor parenchymal and stromal factors, and the ctritical role of …

[HTML][HTML] Development of Dl1. 72, a novel anti-DLL1 antibody with anti-tumor efficacy against estrogen receptor-positive breast cancer

G Silva, J Sales-Dias, D Casal, S Alves, G Domenici… - Cancers, 2021 - mdpi.com
Simple Summary Over 70% of breast cancers (BCs) are estrogen receptor-positive (ER+).
The development of endocrine therapy has considerably improved patient outcomes …